Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002
- PMID: 15897984
- DOI: 10.1086/430325
Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002
Abstract
Background: Varicella zoster virus (VZV) causes varicella and, later in the life of the host, may reactivate to cause herpes zoster (HZ). Because it is hypothesized that exposure to varicella may boost immunity to latent VZV, the vaccination-associated decrease in varicella disease has led some to suggest that the incidence of HZ might increase. We assessed the impact that varicella vaccination has on the incidence of varicella and of HZ.
Methods: Codes for cases of varicella and of HZ in an HMO were determined in automated databases of inpatients and outpatients, on the basis of the Ninth Revision of the International Classification of Diseases. We calculated the incidence, during 1992-2002, of varicella and of HZ.
Results: The incidence of HZ remained stable as the incidence of varicella decreased. Age-adjusted and -specific annual incidence rates of varicella decreased steadily, starting with 1999. The age-adjusted rates decreased from 2.63 cases/1000 person-years during 1995 to 0.92 cases/1000 person-years during 2002; among children 1-4 years old, there was a 75% decrease between 1992-1996 and 2002. Age-adjusted and -specific annual incidence rates of HZ fluctuated slightly over time; the age-adjusted rate was highest, at 4.05 cases/1000 person-years, in 1992, and was 3.71 cases/1000 person-years in 2002.
Conclusions: Our findings revealed that the vaccination-associated decrease in varicella disease did not result in an increase in the incidence of HZ. These early findings will have to be confirmed as the incidence of varicella disease continues to decrease.
Comment in
-
Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination.J Infect Dis. 2005 Jun 15;191(12):1999-2001. doi: 10.1086/430328. Epub 2005 May 12. J Infect Dis. 2005. PMID: 15897983 No abstract available.
Similar articles
-
Universal varicella vaccination: efficacy trends and effect on herpes zoster.Int J Toxicol. 2005 Jul-Aug;24(4):205-13. doi: 10.1080/10915810591000659. Int J Toxicol. 2005. PMID: 16126614
-
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31. Rev Epidemiol Sante Publique. 2008. PMID: 18951741 French.
-
The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. J Infect Dis. 2008. PMID: 18419401 Review.
-
The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16. Pediatr Infect Dis J. 2009. PMID: 19536039
-
The effect of vaccination on the epidemiology of varicella zoster virus.J Infect. 2002 May;44(4):211-9. doi: 10.1053/jinf.2002.0988. J Infect. 2002. PMID: 12099726 Review.
Cited by
-
The incidence of herpes zoster in China: A meta-analysis and evidence quality assessment.Hum Vaccin Immunother. 2023 Aug 1;19(2):2228169. doi: 10.1080/21645515.2023.2228169. Epub 2023 Jul 9. Hum Vaccin Immunother. 2023. PMID: 37424092 Free PMC article. Review.
-
Association between a History of herpes zoster and the risk of Sjögren's syndrome: a nationwide, population-based, case-control study.BMJ Open. 2022 Oct 14;12(10):e061962. doi: 10.1136/bmjopen-2022-061962. BMJ Open. 2022. PMID: 36241353 Free PMC article.
-
Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.BMC Med. 2022 Oct 8;20(1):387. doi: 10.1186/s12916-022-02534-7. BMC Med. 2022. PMID: 36209074 Free PMC article.
-
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35340552 Free PMC article. Review.
-
Herpes zoster of orofacial region.J Oral Maxillofac Pathol. 2021 Sep-Dec;25(3):557. doi: 10.4103/jomfp.jomfp_212_21. Epub 2022 Jan 11. J Oral Maxillofac Pathol. 2021. PMID: 35281131 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
